Institutional Area‚ Behind the Grand Hotel‚ Vasant Kunj‚ New Delhi – 110070 Tel.: 2612409090 / 91; Fax: 26124092 E-mail: administration@srisim.org; Website: www.srisim.org DEVELOPMENT DAY PROJECT REPORT STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. | MANAGING THROUGH WISDOM INTRODUCTION The
Premium Pharmaceutical industry Pharmacology Drug discovery
TRAPHACO JOIN STOCK COMPANY (TRA) DOMESCO MEDICAL IMPORT-EXPORT JOIN STOCK COMPANY (DMC) HAUGIANG PHARMACEUTICAL JOIN STOCK COMPANY (DHG) IMEXPHARM PHARMACEUTICAL JOIN STOCK COMPANY (IMP) gROUP PHARMACEUTICAL: truong quang khoa huynh minh tri Cao huynh ngoc khanh huynh le phuong thao ngo thi ngoc anh to ha cat anh Contents 1 INTRODUCTION 1.1 INDUSTRIAL OVERVIEW Pharmaceutical industry is an important sector in the national economy‚ the production of functional medicine service
Premium Generally Accepted Accounting Principles Asset Balance sheet
The global pharmaceutical industry – in the land of shrinking giants. 1. Introduction The case describes the evolution of the industry and its unusual strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical need‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D
Premium Strategic management Industry Management
MARKETING PROBLEMS OF SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA TABLE OF CONTENT Title page Certification Dedication Acknowledgement Abstract Table of content CHAPTER ONE 0. INTRODUCTION OF “MARKETING PROBLEMS OF SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA 1. Background of the Study 2. Statement of the problem 3. Objective of the Study 4. Research Hypothesis 5. Scope of the Study 6. Significance of the Study
Free E-mail E-mail address Telephone
forces affecting the global pharmaceutical industry? Do these forces differ by industry sector‚ and where would you place the different sectors in the industry life-cycle? Porter’s five forces help identify their attractiveness in the industry in terms of the five competitive forces which are: the threat to entry‚ the threat of substitutes‚ the power of buyers‚ the power of suppliers and the extent of rivalry between the competitors. Where the forces are high‚ industries are not attractive to compete
Premium Barriers to entry Porter five forces analysis Pharmaceutical industry
Historical background of the business Today Merck & Co‚ Inc. is one of the most recognizable companies in the pharmaceutical industry. When asked about Merck‚ most people think that it is and always has been a US company. However‚ the company’s history can be traced all the way back to the 1600’s where it was started in Darmstadt‚ Germany. Friedrich Jacob Merck purchased a local store in 1668 where he prepared and sold medicines. The store was called “At the sign of the Angels” and would remain
Premium
PFIZER CASE The pharmaceutical industry has to continuously develop new products (patents). The different phases requested ahead a new product launch involves long gestation periods‚ and the development of a new product takes around 10 to 15 years. In general‚ most large pharmaceutical firms have a centralized R&D unit. R&D trends in Pharmaceutical industry: In the past‚ increase of R&D costs for a new drug (for one: 1975: € 150m / 1987: € 344m / 2000: € 870m 1/3 of all medicines
Free Pharmacology Pharmacy Medicine
Study-The global pharmaceutical industry-in the land of shrinking giants‚ Johnson‚ G.‚ Scholes‚ K.‚ Whittington‚ R.‚ Angwin‚ D.‚ and Regner‚ P. (2014) “Exploring Strategy‚ text and cases”. Publisher: Prentice Hall‚ pp.549-558. Questions: 1. Identify the main environmental forces which affect the global pharmaceutical industry. 2. Analyse the Five Forces framework to identify environmental forces affecting the global pharmaceutical industry. Do these forces differ by industry sector and where would
Premium Strategic management Aer Lingus Case study
| David Messer | 4/29/2013 | | David Messer Jeremy Black Business 220 April 29‚ 2013 GlaxoSmithKline GlaxoSmithKline is a U.K.-based pharmaceutical powerhouse formed by a merger in the late 90’s‚ with the most important merger being that between Glaxo Wellcome and Smith Kline Beecham. The merger created a pharmaceutical industry giant with operations in over 100 countries and annual sales over $25 billion. In the U.S. alone‚ prescription drugs account for 10% of all medical costs
Premium
The Pharmaceutical Industry: Key success factors High profit after launching the product: Before a pharmaceutical company establishes a new product it takes them a lot time and work. The whole project‚ from the beginning until the end‚ where the medicine can be launched can last about 12 years. But once the drug is on marked the producing company has very high margins. On average‚ a Blockbuster drug is for about eight years on the marked and each year it has revenues in the range of one
Premium Pharmacology Medicine Pharmaceutical drug